This Medudy course is a video tutorial for physicians on the topic of “Patient-Specific Treatment Decisions in the Management of HER2-Positive Breast Cancer.”
In this course, Prof. Dr. Maggie Barys-Paluchowski, Deputy Director of the Department of Obstetrics and Gynecology at UKSH Lübeck, explores the factors that must be considered in everyday clinical practice in order to make patient-centered treatment decisions for HER2-positive breast cancer. In doing so, she examines not only established first-line therapies but also new therapeutic approaches, such as the combination of the antibody-drug conjugate trastuzumab deruxtecan (T-DXd) with pertuzumab.
Note: All “speakers” appearing in the Medudy videos are AI-based avatars used to enhance the educational value of the videos. The individuals on whom the avatars are based have explicitly consented to their use. The video content was created and reviewed by the editorial team with the aid of AI, based on high-quality scientific sources, and has been approved by the speakers.
This course was developed with the kind support of Daiichi Sankyo.
By the end of this course, you will know:
- Guideline-Based Treatment Decisions in the Metastatic HER2+ Setting
- For which patients is the combination of T-DXd and pertuzumab appropriate?
- Compatibility of the Individual Therapies
- the individualized risk assessment for a treatment decision
